GLAXOSMITHKLINE Gains $945.11 Million Contract Modification
Copyright © Targeted News Service 2022
2022-01-16
WASHINGTON, Jan. 16 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on Jan. 12, 2022:
GLAXOSMITHKLINE LLC, Durham, North Carolina, was awarded a $945,107,496 modification to a contract (W58P05-22-C-0002) to procure an additional 340,048 doses of Sotrovimab therapeutic treatment, with an option to procure an additional 715,680 doses by June 30, 2022.
The U.S. Army Contracting Command, Aberdeen Proving Ground, . . .
GLAXOSMITHKLINE LLC, Durham, North Carolina, was awarded a $945,107,496 modification to a contract (W58P05-22-C-0002) to procure an additional 340,048 doses of Sotrovimab therapeutic treatment, with an option to procure an additional 715,680 doses by June 30, 2022.
The U.S. Army Contracting Command, Aberdeen Proving Ground, . . .
